| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 |
| filingDate |
1995-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93fb58b98dae7be8837a91081789f69c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_877a4d2c1deb3a3e97cba919d8982008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da2752981fee7357b9559d5fc7945757
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_620f2da31e8f21fe87df70e6a8f72281 |
| publicationDate |
2000-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1002529-A1 |
| titleOfInvention |
Sustained-release preparation containing a metal salt of a peptide |
| abstract |
A sustained-release preparation containing a water-insolublenor slightly water-soluble polyvalent metal saltnof a water-soluble peptide type of physiologically activensubstance except for an endothelin antagonist and anbiodegradable polymer. nThe present invention is a sustained-release preparationnthat is highly efficient in incorporating a water-solublenpeptide type of physiologically active substance except fornan endothelin antagonist and suppresses initial burst ofnthe water-soluble peptide type of physiologically activensubstance except for an endothelin antagonist. Thensustained-release preparation of the present invention isncapable of releasing the water-soluble peptide type ofnphysiologically active substance except for an endothelinnantagonist while retaining its bioactivity afternadministration in vivo . Furthermore, the water-solublenpeptide type of physiologically active substance except fornan endothelin antagonist in the sustained-releasenpreparation is kept stable for a long period of time, withnlittle loss of bioactivity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004084871-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004096179-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100361651-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100364499-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7642230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7527809-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916206-B2 |
| priorityDate |
1994-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |